Schering-Plough's Nasonex "superior in scent and taste to GSK's Flonase"

l US drugmaker Schering-Plough says that results of a head-to-head study comparing the scent and taste of its allergic rhinitis nasal spray remedy Nasonex (mometasone furoate monohydrate) 50mcg to GlaxoSmithKline's Flonase (fluticasone propionate) nasal spray showed twice the number of patients preferred Nasonex, which is scent-free and alcohol-free, when asked to consider attributes such as immediate taste and after-taste. Efficacy was not measured. According to the study, which was published in the latest issue of the journal Treatments in Respiratory Medicine, patients also said they would be more likely to comply with a Nasonex regimen.